Review: could Methotrexate cause Venoocclusive liver disease?
Summary: Venoocclusive liver disease is found among people who take Methotrexate, especially for people who are male, 2-9 old, have been taking the drug for < 1 month, also take medication Cyclosporine, and have Bone marrow conditioning regimen.
We study 129,925 people who have side effects while taking Methotrexate from FDA and social media. Among them, 303 have Venoocclusive liver disease. Find out below who they are, when they have Venoocclusive liver disease and more.
You are not alone: join a support group for people who take Methotrexate and have Venoocclusive liver disease >>>
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. (latest outcomes from 131,267 Methotrexate users)
Venoocclusive liver disease
Venoocclusive liver disease (small veins in the liver are obstructed) has been reported by people with acute myeloid leukaemia, stem cell transplant, prophylaxis against graft versus host disease, bone marrow conditioning regimen, bone marrow transplant. (latest reports from 1,563 Venoocclusive liver disease patients)
On Apr, 18, 2015: 129,925 people reported to have side effects when taking Methotrexate. Among them, 303 people (0.23%) have Venoocclusive Liver Disease.
Time on Methotrexate when people have Venoocclusive liver disease * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Venoocclusive liver disease||92.68%||3.66%||0.00%||3.66%||0.00%||0.00%||0.00% |
Gender of people who have Venoocclusive liver disease when taking Methotrexate * :
|Venoocclusive liver disease||42.81%||57.19% |
Age of people who have Venoocclusive liver disease when taking Methotrexate * :
|Venoocclusive liver disease||5.88%||24.31%||14.12%||16.47%||4.31%||10.98%||19.22%||4.71% |
Severity of Venoocclusive liver disease when taking Methotrexate ** :
How people recovered from Venoocclusive liver disease ** :
Top conditions involved for these people * :
- Bone marrow conditioning regimen (46 people, 15.18%)
- Graft versus host disease (46 people, 15.18%)
- Prophylaxis (40 people, 13.20%)
- Bone marrow transplant (38 people, 12.54%)
- Acute lymphocytic leukaemia (24 people, 7.92%)
Top co-used drugs for these people * :
- Cyclosporine (132 people, 43.56%)
- Cyclophosphamide (126 people, 41.58%)
- Tacrolimus (91 people, 30.03%)
- Prograf (66 people, 21.78%)
- Acyclovir (52 people, 17.16%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of Methotrexate and venoocclusive liver disease on
Do you have Venoocclusive Liver Disease while taking Methotrexate?
You are not alone! Join a support group on :
- support group for people who take Methotrexate and have Venoocclusive Liver Disease
- support group for people who take Methotrexate
- support group for people who have Venoocclusive Liver Disease
Drugs in real world that are associated with:
Could your condition cause:
Recent Methotrexate related drug comparison:
- Comparions of Azathioprine, Humira, Enbrel, Sulfadiazine, Methotrexate for a 42-year old woman who has Psoriatic Arthritis
- Comparions of Methotrexate, Furosemide for a 55-year old man who has Arthritis
- Comparions of Methotrexate, Aloe Vera Gel for a 64-year old woman who has Arthritis
- Comparions of Arava, Methotrexate, Humira, Remicade for a 55-year old woman who has Seronegative Arthritis
- Comparions of Prednisone, Folic Acid, Methotrexate for a 64-year old man who has Tenosynovitis
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.